ApprovalTrail

Approval · Notice of Compliance 24703 · 2020

PERSANTINE: Notice of Compliance 24703

Issued November 30, 2020

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
24703
Date
November 30, 2020
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Change in product ownership

Products in this notice

BrandDINStatus today
PERSANTINE00637734Marketed

Medicinal ingredients